‘Weight Management’ Guidance Changes From FDA Could Tip Scales In Obesity Reimbursement Debate

 
• By Sarah Karlin-Smith

Expected revision to the 2007 draft might more clearly communicate that obesity is a disease than the earlier guidance, and could provide advice on getting indications for treating complications. If US FDA embraces the new thinking, it could help build the case for Medicare reimbursement.

feet of person weighing themselves on scale
Updates to a nearly 20-year old FDA guidance could help manufacturers’ in their quest for obesity drug coverage. • Source: Shutterstock

More from Approval Standards

More from Pathways & Standards